Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Neuroendocrine Tumors”

1,846 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,846 results

Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT05419388
What this trial is testing

Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Hoffmann-La Roche 93
Early research (Phase 1)WithdrawnNCT02068079
What this trial is testing

A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma

Who this might be right for
Melanoma
Duke University
Testing effectiveness (Phase 2)Ended earlyNCT00707161
What this trial is testing

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

Who this might be right for
CancerMelanoma
University of Utah 6
Testing effectiveness (Phase 2)Study completedNCT00398320
What this trial is testing

Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Pamela L. Kunz 40
Testing effectiveness (Phase 2)Study completedNCT00590343
What this trial is testing

Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors

Who this might be right for
Metastatic Neuroendocrine Tumors
Louisiana State University Health Sciences Center in New Orleans 23
Testing effectiveness (Phase 2)Looking for participantsNCT06953089
What this trial is testing

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumors
DualityBio Inc. 492
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Not applicableEnded earlyNCT03947762
What this trial is testing

Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

Who this might be right for
Pancreatic Neuroendocrine Tumor
Ipsen 54
Early research (Phase 1)Study completedNCT03289962
What this trial is testing

Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
MelanomaNon-Small Cell Lung CancerBladder Cancer+5 more
Genentech, Inc. 272
Testing effectiveness (Phase 2)Ended earlyNCT01925118
What this trial is testing

Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2

Who this might be right for
Metastatic Malignant Melanoma and Renal Cell Carcinoma
Seoul National University Hospital 9
Early research (Phase 1)Looking for participantsNCT06204991
What this trial is testing

To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVMelanoma
Inge Marie Svane 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848337
What this trial is testing

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticNeuroendocrine Tumors
University of Michigan Rogel Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00020475
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Extraocular Extension MelanomaRecurrent Intraocular Melanoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00669019
What this trial is testing

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)UnknownNCT03422029
What this trial is testing

Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients

Who this might be right for
Neuroendocrine Tumors
Peking University 20
Early research (Phase 1)Study completedNCT04165967
What this trial is testing

Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

Who this might be right for
Advanced Melanoma
University Hospital, Basel, Switzerland 9
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Study completedNCT01280201
What this trial is testing

Pazopanib as Single Agent in Advanced NETs

Who this might be right for
Advanced/Metastatic Neuroendocrine Tumors
Grupo Espanol de Tumores Neuroendocrinos 44
Load More Results